The drugmaker will encounter patent cliffs for two of its best-selling medicines by the end of the decade: anticoagulant ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...